ArticleBMC cancer2017

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133

Federica Brugnoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.